Erratum to Retraction: In vitro osteoinduction of human mesenchymal stem cells in biomimetic surface modified titanium alloy implants (Dental Materials Journal, (2012), 31, 5, (843-850), 10.4012/dmj.2012-015);In vitro osteoinduction of human mesenchymal stem cells in biomimetic surface modified titanium alloy implants

Dental Materials Journal

Volumn 31, Issue 5, 2012, Pages 843-850

  Santander, Sonia ^a,b,c   Alcaine, Clara ^a,b,c   Lyahyai, Jaber ^b,c   Pérez, Maria Angeles ^a,b,c   Rodellar, Clementina ^b,c   Doblaré, Manuel ^a,b,c   Ochoa, Ignacio ^a,b,c  

^a BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

^b UNIVERSITY OF ZARAGOZA   (Spain)

^c INSTITUTO ARAGONÉS DE CIENCIAS DE LA SALUD   (Spain)

Author keywords

Biomimetic surface; Combined surface treatment; Human mesenchymal stem cells; Osteoinduction; Titanium implant

Indexed keywords

BIOMIMETICS; CALCIUM COMPOUNDS; CELL CULTURE; CHEMICAL MODIFICATION; METAL CLEANING; METAL IMPLANTS; STEM CELLS; TITANIUM ALLOYS; TITANIUM OXIDES;

BIOMIMETIC SURFACES; COMBINED SURFACE TREATMENT; HUMAN MESENCHYMAL STEM CELLS; OSTEOINDUCTION; TITANIUM IMPLANTS;

SURFACE TREATMENT;

ALUMINUM OXIDE; BIOMATERIAL; BIOMIMETIC MATERIAL; CALCIUM PHOSPHATE; DENTAL ALLOY; OSTEOPONTIN; RUNX2 PROTEIN, HUMAN; TITANIUM; TITANIUM ALLOY (TIAL6V4); TITANIUM DIOXIDE; TRANSCRIPTION FACTOR RUNX2;

ARTICLE; BONE DEVELOPMENT; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SHAPE; CHEMISTRY; COMPARATIVE STUDY; CULTURE TECHNIQUE; ELECTROCHEMICAL ANALYSIS; HUMAN; MESENCHYMAL STROMA CELL; METABOLISM; OSTEOBLAST; PHYSIOLOGY; POROSITY; REAL TIME POLYMERASE CHAIN REACTION; SCANNING ELECTRON MICROSCOPY; SURFACE PROPERTY; TOOTH IMPLANT; X RAY PHOTOELECTRON SPECTROSCOPY;

ALUMINUM OXIDE; BIOMIMETIC MATERIALS; CALCIUM PHOSPHATES; CELL ADHESION; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SHAPE; COATED MATERIALS, BIOCOMPATIBLE; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DENTAL ALLOYS; DENTAL IMPLANTS; ELECTROCHEMICAL TECHNIQUES; HUMANS; MESENCHYMAL STROMAL CELLS; MICROSCOPY, ELECTRON, SCANNING; OSTEOBLASTS; OSTEOGENESIS; OSTEOPONTIN; PHOTOELECTRON SPECTROSCOPY; POROSITY; REAL-TIME POLYMERASE CHAIN REACTION; SURFACE PROPERTIES; TITANIUM;

EID: 84867859286     PISSN: 02874547     EISSN: 18811361     Source Type: Journal    
DOI: 10.4012/dmj.2012-015-e     Document Type: Erratum

References (57)

1. Wall I, Donos N, Carlqvist K, Jones F, Brett P. Modified titanium surfaces promote accelerated osteogenic differentiation of mesenchymal stromal cells in vitro. Bone 2009; 45: 17-26.
2. Lavenus S, Louarn G, Layrolle P. Nanotechnology and dental implants. Int J Biomater 2010; 2010: 915327.
3. Puleo DA, Nanci A. Understanding and controlling the boneimplant interface. Biomaterials 1999; 20: 2311-2321.
4. Heo YY, Um S, Kim SK, Park JM, Seo B. Responses of periodontal ligament stem cells on various titanium surfaces. Oral Dis 2010; 17: 320-327.
5. Nayab SN, Jones FH, Olsen I. Effects of calcium ionimplantation of titanium on bone cell function in vitro. J Biomed Mater Res A 2007; 83: 296-302.
6. Mangano C, De Rosa A, Desiderio V, d'Aquino R, Piattelli A, De Francesco F, Tirino V, Mangano F, Papaccio G. The osteoblastic differentiation of dental pulp stem cells and bone formation on different titanium surface textures. Biomaterials 2010; 31: 3543-3551.
7. Albrektsson T, Brånemark PI, Hansson HA, Lindström J. Osseointegrated titanium implants. Requirements for ensuring a long-lasting, direct bone-to-implant anchorage in man. Acta Orthop Scand 1981; 52: 155-170.
8. Røynesdal AK, Ambjørnsen E, Støvne S, Haanaes HR. A comparative clinical study of three different endosseous implants in edentulous mandibles. Int J Oral Maxillofac Implants 1998; 13: 500-505.
9. Porter JA, von Fraunhofer JA. Success or failure of dental implants? A literature review with treatment considerations. Gen Dent 2005; 53: 423-432; quiz 433, 446.
10. Ellingsen JE, Johansson CB, Wennerberg A, Holmén A. Improved retention and bone-tolmplant contact with fluoridemodified titanium implants. Int J Oral Maxillofac Implants 2004; 19: 659-666.
11. Sul YT, Johansson C, Byon E, Albrektsson T. The bone response of oxidized bioactive and non-bioactive titanium implants. Biomaterials 2005; 26: 6720-6730.
12. Lamolle SF, Monjo M, Rubert M, Haugen HJ, Lyngstadaas SP, Ellingsen JE. The effect of hydrofluoric acid treatment of titanium surface on nanostructural and chemical changes and the growth of MC3T3-E1 cells. Biomaterials 2009; 30: 736-742.
13. Monjo M, Lamolle SF, Lyngstadaas SP, Rønold HJ, Ellingsen JE. In vivo expression of osteogenic markers and bone mineral density at the surface of fluoride-modified titanium implants. Biomaterials 2008; 29: 3771-3780.
14. Meirelles L, Albrektsson T, Kjellin P, Arvidsson A, Franke- Stenport V, Andersson M, Currie F, Wennerberg A. Bone reaction to nano hydroxyapatite modified titanium implants placed in a gap-healing model. J Biomed Mater Res A 2008; 87: 624-631.
15. Meirelles L, Arvidsson A, Andersson M, Kjellin P, Albrektsson T, Wennerberg A. Nano hydroxyapatite structures influence early bone formation. J Biomed Mater Res A 2008; 87: 299-307.
16. Yang Y, Kim KH, Ong JL. A review on calcium phosphate coatings produced using a sputtering process -an alternative to plasma spraying. Biomaterials 2005; 26: 327-337.
17. Coelho PG, Cardaropoli G, Suzuki M, Lemons JE. Early healing of nanothickness bioceramic coatings on dental implants. An experimental study in dogs. J Biomed Mater Res B Appl Biomater 2009; 88: 387-393.
18. Albrektsson T, Wennerberg A. Oral implant surfaces: Part 1-review focusing on topographic and chemical properties of different surfaces and in vivo responses to them. Int J Prosthodont 2004; 17: 536-543.
19. Albrektsson T, Wennerberg A. Oral implant surfaces: Part 2-review focusing on clinical knowledge of different surfaces. Int J Prosthodont 2004; 17: 544-564.
20. Park JW, Kim YJ, Park CH, Lee DH, Ko YG, Jang JH, Lee CS. Enhanced osteoblast response to an equal channel angular pressing-processed pure titanium substrate with microrough surface topography. Acta Biomater 2009; 5: 3272-3280.
21. Conserva E, Lanuti A, Menini M. Cell behavior related to implant surfaces with different microstructure and chemical composition: an in vitro analysis. Int J Oral Maxillofac Implants 2010; 25: 1099-1107.
22. Raines AL, Olivares-Navarrete R, Wieland M, Cochran DL, Schwartz Z, Boyan BD. Regulation of angiogenesis during osseointegration by titanium surface microstructure and energy. Biomaterials 2010; 31: 4909-4917.
23. Zhang F, Yang GL, He FM, Zhang LJ, Zhao SF. Cell response of titanium implant with a roughened surface containing titanium hydride: an in vitro study. J Oral Maxillofac Surg 2010; 68: 1131-1139.
24. Le Guéhennec L, Soueidan A, Layrolle P, Amouriq Y. Surface treatments of titanium dental implants for rapid osseointegration. Dent Mater 2007; 23: 844-854.
25. Eriksson C, Lausmaa J, Nygren H. Interactions between human whole blood and modified TiO2-surfaces: influence of surface topography and oxide thickness on leukocyte adhesion and activation. Biomaterials 2001; 22: 1987-1996.
26. Brunette DM. The effects of implant surface topography on the behavior of cells. Int J Oral Maxillofac Implants 1988; 3: 231-246.
27. Martin JY, Schwartz Z, Hummert TW, Schraub DM, Simpson J, Lankford J, Dean DD, Cochran DL, Boyan BD. Effect of titanium surface roughness on proliferation, differentiation, and protein synthesis of human osteoblast-like cells (MG63). J Biomed Mater Res 1995; 29: 389-401.
28. Jayaraman M, Meyer U, Bühner M, Joos U, Wiesmann HP. Influence of titanium surfaces on attachment of osteoblastlike cells in vitro. Biomaterials 2004; 25: 625-631.
29. Schwartz Z, Lohmann CH, Oefinger J, Bonewald LF, Dean DD, Boyan BD. Implant surface characteristics modulate differentiation behavior of cells in the osteoblastic lineage. Adv Dent Res 1999; 13: 38-48.
30. Damsky CH. Extra cellular matrix-integrin interactions in osteoblast function and tissue remodeling. Bone 1999; 25: 95-96.
31. Hood JD, Cheresh DA. Role of integrins in cell invasion and migration. Nat Rev Cancer 2002; 2: 91-100.
32. Puleo DA, Holleran LA, Doremus RH, Bizios R. Osteoblast responses to orthopedic implant materials in vitro. J Biomed Mater Res 1991; 25: 711-723.
33. Albrektsson T, Johansson C. Osteoinduction, osteoconduction nd osseointegration. Eur Spine J 2001; 10 Suppl 2: S96-S101.
34. Endres S, Wilke M, Knoll P, Frank H, Kratz M, Wilke A. Correlation of in vitro and in vivo results of vacuum plasma sprayed titanium implants with different surface topography. J Mater Sci Mater Med 2008; 19: 1117-1125.
35. Boyd AR, Burke GA, Meenan BJ. Monitoring cellular behaviour using Raman spectroscopy for tissue engineering and regenerative medicine applications. J Mater Sci MaterMed 2010; 21: 2317-2324.
36. Kurella A, Dahotre NB. Review paper: surface modification for bioimplants: the role of laser surface engineering. J Biomater Appl 2005; 20: 5-50.
37. Anselme K, Bigerelle M. Statistical demonstration of the relative effect of surface chemistry and roughness on human osteoblast short-term adhesion. J Mater Sci Mater Med 2006; 17: 471-479.
38. Kieswetter K, Schwartz Z, Hummert TW, Cochran DL, Simpson J, Dean DD, Boyan BD. Surface roughness modulates the local production of growth factors and cytokines by osteoblast-like MG-63 cells. J Biomed Mater Res 1996; 32: 55-63.
39. Boyan BD, Batzer R, Kieswetter K, Liu Y, Cochran DL, Szmuckler-Moncler S, Dean DD, Schwartz Z. Titanium surface roughness alters responsiveness of MG63 osteoblastlike cells to 1 alpha,25-(OH)2D3. J Biomed Mater Res 1998; 39: 77-85.
40. Cheng Z, Liu X, Ou L, Zhou X, Liu Y, Jia X, Zhang J, Li Y, Kong D. Mobilization of mesenchymal stem cells by granulocyte colony-stimulating factor in rats with acute myocardial infarction. Cardiovasc Drugs Ther 2008; 22: 363-371.
41. Omar O, Lennerås M, Svensson S, Suska F, Emanuelsson L, Hall J, Nannmark U, Thomsen P. Integrin and chemokine receptor gene expression in implant-adherent cells during early osseointegration. J Mater Sci Mater Med 2010; 21: 969-980.
42. Qu J, Chehroudi B, Brunette DM. The use of micromachined surfaces to investigate the cell behavioural factors essential to osseointegration. Oral Dis 1996; 2: 102-115.
43. Anselme K, Bigerelle M, Noël B, Iost A, Hardouin P. Effect of grooved titanium substratum on human osteoblastic cell growth. J Biomed Mater Res 2002; 60: 529-540.
44. Llopis-Hernández V, Rico P, Ballester-Beltrán J, Moratal D, Salmerón-Sánchez M. Role of surface chemistry in protein remodeling at the cell-material interface. PLoS One 2011; 6:e19610.
45. Zhu X, Chen J, Scheideler L, Reichl R, Geis-Gerstorfer J. Effects of topography and composition of titanium surface oxides on osteoblast responses. Biomaterials 2004; 25: 4087-4103.
46. Komori T. Regulation of bone development and maintenance by Runx2. Front Biosci 2008; 13: 898-903.
47. Komori T. Regulation of bone development and extracellular matrix protein genes by RUNX2. Cell Tissue Res 2010; 339: 189-195.
48. Malyankar UM, Almeida M, Johnson RJ, Pichler RH, Giachelli CM. Osteopontin regulation in cultured rat renal epithelial cells. Kidney Int 1997; 51: 1766-1773.
49. McKee MD, Nanci A. Osteopontin at mineralized tissue interfaces in bone, teeth, and osseointegrated implants: ultrastructural distribution and implications for mineralized tissue formation, turnover, and repair. Microsc Res Tech 1996; 33: 141-164.
50. Ross FP, Chappel J, Alvarez JI, Sander D, Butler WT, Farach-Carson MC, Mintz KA, Robey PG, Teitelbaum SL, Cheresh DA. Interactions between the bone matrix proteins osteopontin and bone sialoprotein and the osteoclast integrin alpha v beta 3 potentiate bone resorption. J Biol Chem 1993; 268: 9901-9907.
51. McKee MD, Nanci A. Osteopontin deposition in remodeling bone: an osteoblast mediated event. J Bone Miner Res 1996; 11: 873-875.
52. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 1997; 89: 747-754.
53. Karsenty G. The genetic transformation of bone biology. Genes Dev 1999; 13: 3037-3051.
54. Kern B, Shen J, Starbuck M, Karsenty G. Cbfa1 contributes to the osteoblast-specific expression of type I collagen genes. J Biol Chem 2001; 276: 7101-7107.
55. Javed A, Barnes GL, Jasanya BO, Stein JL, Gerstenfeld L, Lian JB, Stein GS. Runt homology domain transcription factors (Runx, Cbfa, and AML) mediate repression of thebone sialoprotein promoter: evidence for promoter contextdependent activity of Cbfa proteins. Mol Cell Biol 2001; 21: 2891-2905.
56. Banerjee C, Hiebert SW, Stein JL, Lian JB, Stein GS. An AML-1 consensus sequence binds an osteoblast-specific complex and transcriptionally activates the osteocalcin gene. Proc Natl Acad Sci U S A 1996; 93: 4968-4973.
57. Thirunavukkarasu K, Halladay DL, Miles RR, Yang X, Galvin RJ, Chandrasekhar S, Martin TJ, Onyia JE. The osteoblast-specific transcription factor Cbfa1 contributesto the expression of osteoprotegerin, a potent inhibitor of osteoclast differentiation and function. J Biol Chem 2000;275: 25163-25172.